Phase 2 study of TLK286 (GST P1-1 Activated Glutathione Analog) in patients with platinum and paclitaxel refractory/resistant advanced epithelial ovarian cancer Meeting Abstract
| Authors: | Kavanagh, J. J.; Kudelka, A.; Spriggs, D. R.; Bookman, M. A.; Lewis, L.; Maack, C.; Dombroski, J.; Macpherson, J.; Henner, W. D.; Brown, G. L. |
| Abstract Title: | Phase 2 study of TLK286 (GST P1-1 Activated Glutathione Analog) in patients with platinum and paclitaxel refractory/resistant advanced epithelial ovarian cancer |
| Meeting Title: | 14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 38 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2002 Nov 19-22 |
| Meeting Location: | Frankfurt, Germany |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2002-11-01 |
| Start Page: | S34 |
| End Page: | S35 |
| Language: | English |
| ACCESSION: | WOS:000179895700101 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(02)80749-3 |
| PUBMED: | 12526123 |
| Notes: | Meeting Abstract: 100 -- 14th EORTC/NCI/AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 19-22, 2002 -- FRANKFURT, GERMANY -- Source: Wos |
